Eton Pharmaceuticals Inc (ETON)
3.68
+0.22
(+6.51%)
USD |
NASDAQ |
May 01, 15:04
Eton Pharmaceuticals Gross Profit Margin (Quarterly): 49.64% for Dec. 31, 2023
Gross Profit Margin (Quarterly) Chart
Historical Gross Profit Margin (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2023 | 49.64% |
| September 30, 2023 | 62.65% |
| June 30, 2023 | 80.70% |
| March 31, 2023 | 63.08% |
| December 31, 2022 | 74.84% |
| September 30, 2022 | 62.69% |
| June 30, 2022 | 62.69% |
| March 31, 2022 | 60.98% |
| December 31, 2021 | 93.89% |
| Date | Value |
|---|---|
| September 30, 2021 | 15.61% |
| June 30, 2021 | 94.33% |
| March 31, 2021 | 86.64% |
| December 31, 2020 | -455.6% |
| September 30, 2020 | 10.56% |
| June 30, 2020 | -40.00% |
| March 31, 2020 | -3.03% |
| December 31, 2019 | 1.31% |
Gross Profit Margin Definition
Gross Profit Margin is calculated using Gross Profit/Revenue. This metric measures the overall efficiency of a company in being able to turn revenue into gross profit and doing this by keeping cost of goods sold low. An analyst looking at gross profit margin might look for a higher gross profit margin relative to other comparable companies as well as a gross profit margin that is growing.
Gross Profit Margin (Quarterly) Range, Past 5 Years
-455.6%
Minimum
Dec 2020
94.33%
Maximum
Jun 2021
18.88%
Average
62.65%
Median
Sep 2023
Gross Profit Margin (Quarterly) Benchmarks
| Evoke Pharma Inc | 96.48% |
| Outlook Therapeutics Inc | -- |
| NovaBay Pharmaceuticals Inc | 48.70% |
| Palatin Technologies Inc | 95.20% |
| iBio Inc | -- |
Gross Profit Margin (Quarterly) Related Metrics
| Return on Equity | -6.37% |
| Return on Assets | -3.27% |
| Return on Invested Capital | -4.52% |
| Profit Margin (Quarterly) | -30.85% |
| Operating Margin (Quarterly) | -27.25% |
| Return on Net Operating Assets | -11.11% |